ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.8331+16C>G (rs730881595)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Color RCV000579621 SCV000683956 likely benign Hereditary cancer-predisposing syndrome 2016-12-19 criteria provided, single submitter clinical testing
Counsyl RCV000662508 SCV000785040 likely benign Breast-ovarian cancer, familial 2 2017-03-20 criteria provided, single submitter clinical testing
GeneDx RCV000160250 SCV000210668 benign not specified 2014-10-01 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Integrated Genetics/Laboratory Corporation of America RCV000589540 SCV000695144 likely benign not provided 2016-04-07 criteria provided, single submitter clinical testing Variant summary: The c.8331+16C>G variant affects a non-conserved nucleotide, resulting in an intronic change at a position not widely known to affect splicing. Mutation Taster predicts benign outcome. 5/5 in silico tools via Alamut predict no effect in consensus splice donor site or no creation of cryptic splice donor sites. The variant was found not to affect splicing in an in vitro minigene assay, suggesting for a benign outcome (Thery_2011). This variant was found in 5/112496 control chromosomes from the broad and large populations of ExAC at a frequency of 0.0000444. It was found only in African subpopulation with an allele frequency of 0.00008 (5/61584 chromosomes). Although the frequency does not exceed the maximal expected frequency of a pathogenic allele (0.0007503) in this gene, it may still suggest that the variant could be a rare polymorphism in Africans. In literature, this variant has been reported in one breast cancer case who also carried a known pathogenic variant BRCA1 185delAG (Hansen_2011), further supporting for a benign outcome. In addition, two clinical laboratories have classified this variant as benign/likely benign. Taken together, the variant has currently been classified as Likely Benign until additional information becomes available.
Invitae RCV000197911 SCV000253047 likely benign Hereditary breast and ovarian cancer syndrome 2017-02-17 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.